Where Industry Meet Trends

ai robot image

Jemincare, with the help of Orion, will be furthering the development of their non-opioid drug JMKX000623, an inhibitor of a main sodium channel subtype that balances out pain fibres’ stimulation. Orion corporation has partnered up with Jemincare where the former will be responsible for the international development and marketing rights of the non-opioid drug. This drug will treat acute as well as chronic pain. In addition to royalty payments, Orion will also make an upfront payment of $15 million to Jemincare.

Read More from Pharmaceutical Technology 

Leave a Reply

Your email address will not be published. Required fields are marked *

Welcome to Industry Trends, your go-to platform for insights and updates on the transformative power of AI and Automation across major industries. Our blog focuses on exploring the latest advancements, disruptions, and innovations shaping the future of Retail, Consumer Goods, Finance, Healthcare, and Manufacturing.

At Industry Trends, we are committed to delivering in-depth analysis, thought-provoking articles, and actionable strategies to help businesses and professionals stay ahead in today’s rapidly evolving digital landscape. Whether it’s the rise of intelligent automation in manufacturing, AI-driven personalization in retail, revolutionary changes in consumer goods, or the latest breakthroughs in healthcare and finance, we bring you the stories that matter the most.

Join us as we delve into the future of these industries and uncover how cutting-edge technology is redefining the way we work, live, and interact. Stay informed, stay inspired, and stay prepared with Industry Trends—where industries meet the power of innovation.

en_USEnglish
en_USEnglish